We are live on ! Find out more
STLNW

Starling Oncology, Inc. Warrant
STLNW

14 hedge funds and large institutions have $132K invested in Starling Oncology, Inc. Warrant in 2023 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 5 increasing their positions, 1 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

400% more repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 1

0% more first-time investments, than exits

New positions opened: 1 | Existing positions closed: 1

0.33% less ownership

Funds ownership: 6.15% → 5.82% (-0.33%)

7% less funds holding

Funds holding: 15 → 14 (-1)

90% less capital invested

Capital invested by funds: $1.3M → $132K (-$1.16M)

Holders
14
Holders Change
-1
Holders Change %
-6.67%
% of All Funds
0.22%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
5
Reduced
1
Closed
1
Calls
$5K
Puts
–
Net Calls
+$5K
Net Calls Change
-$5K

Top Buyers

Rank Fund Capital Flow
1
Man Group
Man Group
United Kingdom
+$5.21K
2
Walleye Capital
Walleye Capital
New York
+$1.66K
3
Citadel Advisors
Citadel Advisors
Florida
+$589
4
CAC
Cowen and Company
New York
+$17
5
CS
Clear Street
New York
+$11

Top Sellers

Rank Fund Capital Flow
1
DCM
Difesa Capital Management
New York
-$1.83K
2
Bank of America
Bank of America
North Carolina
-$6
Name Holding Trade Value Shares
Change 		Change in
Stake
LP
1
LMR Partners
United Kingdom
$43.8K – – –
DM
2
Deerfield Management
New York
$34.9K – – –
Walleye Capital
3
Walleye Capital
New York
$14.2K +$1.66K +30,242 +6%
DKCM
4
Davidson Kempner Capital Management
New York
$8.86K – – –
HCM
5
Highbridge Capital Management
New York
$7.32K – – –
Man Group
6
Man Group
United Kingdom
$4.26K +$5.21K +94,740 New
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
7
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Ontario, Canada
$3.94K – – –
DCM
8
Difesa Capital Management
New York
$3.72K -$1.83K -33,226 -29%
CAC
9
Cowen and Company
New York
$3.36K +$17 +300 +0.2%
JFG
10
Jefferies Financial Group
New York
$2.65K – – –
WAM
11
Wolverine Asset Management
Illinois
$2.33K +$11 +200 +0.2%
Citadel Advisors
12
Citadel Advisors
Florida
$1.26K +$589 +10,703 +62%
AGM
13
Alpine Global Management
New York
$1.13K – – –
TCM
14
Tenor Capital Management
New York
$698 – – –
CS
15
Clear Street
New York
$11 +$11 +200 +104%
Bank of America
16
Bank of America
North Carolina
– -$6 -100 Closed

STLNW Hedge Fund Activity: Q2 2023 in Review

14 of the 6,371 institutional investors tracked by Wall St. Rank reported a position in Starling Oncology, Inc. Warrant (STLNW) for Q2 2023, worth a combined $132K — down 90% from $1.3M a quarter earlier.

Fund positioning in STLNW was balanced in Q2 2023: 1 fund opened new positions, 1 closed out, 5 added to existing stakes and 1 trimmed.

The largest buyer was Man Group, opening a new position worth an estimated $5.21K. The largest seller was Difesa Capital Management, cutting an estimated $1.83K.

  • 14 institutional investors held Starling Oncology, Inc. Warrant (STLNW) as of Q2 2023, down from 15 in Q1 2023.
  • Funds reported $132K of Starling Oncology, Inc. Warrant stock for Q2 2023, down 90% quarter-over-quarter.
  • 1 fund opened new Starling Oncology, Inc. Warrant positions in Q2 2023 and 1 closed out, a net change of 0 holders.
  • The largest Starling Oncology, Inc. Warrant buyer in Q2 2023 was Man Group, an estimated $5.21K added.
  • The largest Starling Oncology, Inc. Warrant seller in Q2 2023 was Difesa Capital Management, an estimated $1.83K sold.

Based on aggregated 13F filings for Q2 2023.